2020
DOI: 10.1016/j.biopha.2020.110305
|View full text |Cite
|
Sign up to set email alerts
|

GSH attenuates RANKL-induced osteoclast formation in vitro and LPS-induced bone loss in vivo

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
26
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 22 publications
(27 citation statements)
references
References 28 publications
1
26
0
Order By: Relevance
“…Literature mining shows that RANKL induced osteoclastogenesis is augmented by depletion of B 6 or B 12 in media. Knock down of CBS which came up as a critical gene in three of the four data set in our integrated analysis increased osteoclastogenesis, while supplementation of glutathione was shown to inhibit osteoclastogenesis 68 . CBS KO mice showed increased osteoclastogenesis and osteoporosis which could be mitigated by supplementation of N-acetyl cysteine.…”
Section: Discussionmentioning
confidence: 81%
“…Literature mining shows that RANKL induced osteoclastogenesis is augmented by depletion of B 6 or B 12 in media. Knock down of CBS which came up as a critical gene in three of the four data set in our integrated analysis increased osteoclastogenesis, while supplementation of glutathione was shown to inhibit osteoclastogenesis 68 . CBS KO mice showed increased osteoclastogenesis and osteoporosis which could be mitigated by supplementation of N-acetyl cysteine.…”
Section: Discussionmentioning
confidence: 81%
“…NAC treatment enhanced ALP activity in the process of osteogenic differentiation, which was related to the increased GSH/GSSG ratio in NAC-treated cells [38]. GSH suppressed RANKL-induced osteoclastogenesis by inhibiting intracellular ROS generation [39]. Our results presented that NAC supplement inhibited the elevation of ROS production and enhanced the level of GSH and the ratio of GSH/GSSG in PDLSCs, suggesting that NAC application improved antioxidant capacity through decreased ROS production and the increased ratio of GSH/GSSG, which might contribute to the promotion of osteogenic differentiation in PDLSCs under cyclic mechanical stretch.…”
Section: Discussionmentioning
confidence: 90%
“…Previous reports on ROS production and RANKL-induced osteoclastogenesis have shown that ROS levels regulate expression and activity of differentiation factors during osteoclastogenesis, thereby determining the number of mature osteoclasts and bone density, but that ROS levels do not affect osteoblastogenesis (Kim et al, 2010, Kim J.H. et al, 2015Goettsch et al, 2013;Hyeon et al, 2013;Kang and Kim, 2016;Lee et al, 2019;Ng et al, 2019;Han et al, 2020). Lee et al (2019) has recently reported that reduction in osteoclast differentiation and increased bone density through regulation of ROS signaling result from reduced RANKL secretion by osteoblasts.…”
Section: Discussionmentioning
confidence: 99%